SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4zch'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TMX_B_BEZB882_0 (HYDROXYQUINOL 1,2-DIOXYGENASE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	LEU A 431 TYR A 360 ILE A 429 HIS A 369 VAL A 325	None	1.37A	1tmxB-4zchA: undetectable	1tmxB-4zchA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VE3_A_SAMA302_0 (HYPOTHETICAL PROTEIN PH0226)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	ALA A 256 GLY A 205 SER A 105 ILE A 203 PHE A 353	None	1.15A	1ve3A-4zchA: undetectable	1ve3A-4zchA: 20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VE3_B_SAMB301_0 (HYPOTHETICAL PROTEIN PH0226)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	ALA A 256 GLY A 205 SER A 105 ILE A 203 PHE A 353	None	1.14A	1ve3B-4zchA: undetectable	1ve3B-4zchA: 20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_B_CQAB400_0 (HISTAMINE N-METHYLTRANSFERASE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	SER A 102 GLN A 60 TYR A 254 VAL A 108 PHE A 353	None	1.37A	2aouB-4zchA: 0.0	2aouB-4zchA: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIA_B_CL9B401_1 (DEOXYCYTIDINE KINASE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	VAL A 174 TRP A 176 LEU A 269 PHE A 286 TYR A 254	None	1.28A	2ziaB-4zchA: undetectable	2ziaB-4zchA: 21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIA_B_CL9B401_1 (DEOXYCYTIDINE KINASE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	VAL A 325 TRP A 327 LEU A 420 PHE A 437 TYR A 405	None	1.29A	2ziaB-4zchA: undetectable	2ziaB-4zchA: 21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZN_A_SAMA401_0 (UNCHARACTERIZED PROTEIN MJ0883)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	LEU A 56 PHE A 201 GLY A 288 ASP A 265 VAL A 195	None	1.28A	2zznA-4zchA: undetectable	2zznA-4zchA: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A79_A_P1BA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	LEU A 186 ILE A 203 ILE A 193 PHE A 286 TYR A 405	None	1.38A	4a79A-4zchA: undetectable	4a79A-4zchA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A79_B_P1BB601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	LEU A 186 ILE A 203 ILE A 193 PHE A 286 TYR A 405	None	1.31A	4a79B-4zchA: undetectable	4a79B-4zchA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A7A_A_RGZA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 11	LEU A 186 ILE A 203 ILE A 193 PHE A 286 TYR A 405	None	1.41A	4a7aA-4zchA: undetectable	4a7aA-4zchA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQ4_A_SALA601_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 420 THR A 436 ILE A 429 GLY A 368	None	0.97A	4eq4A-4zchA: undetectable	4eq4A-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQL_A_SALA602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 269 THR A 285 ILE A 278 GLY A 217	None	0.95A	4eqlA-4zchA: undetectable	4eqlA-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQL_A_SALA602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 420 THR A 436 ILE A 429 GLY A 368	None	0.94A	4eqlA-4zchA: undetectable	4eqlA-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQL_B_SALB602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 420 THR A 436 ILE A 429 GLY A 368	None	0.96A	4eqlB-4zchA: undetectable	4eqlB-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L39_B_SALB601_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 269 THR A 285 ILE A 278 GLY A 217	None	0.87A	4l39B-4zchA: undetectable	4l39B-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L39_B_SALB601_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	LEU A 420 THR A 436 ILE A 429 GLY A 368	None	0.88A	4l39B-4zchA: undetectable	4l39B-4zchA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZJL_D_ERYD1101_0 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	SER A 403 SER A 59 PHE A 286 LEU A 62 ASN A 251	None	1.45A	4zjlD-4zchA: undetectable	4zjlD-4zchA: 18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGI_A_ZITA402_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	ILE A 371 VAL A 358 ALA A 310 VAL A 325 PHE A 331	None	1.05A	5igiA-4zchA: undetectable	5igiA-4zchA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JWA_H_ACTH612_0 (NADH DEHYDROGENASE, PUTATIVE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	3 / 3	ARG A 98 PRO A 93 ASN A 101	None	1.06A	5jwaA-4zchA: undetectable 5jwaH-4zchA: undetectable	5jwaA-4zchA: 22.46 5jwaH-4zchA: 22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V5Z_A_1YNA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	5 / 12	PHE A 136 PHE A 86 GLY A 408 LEU A 56 PHE A 109	None None None None 144 A 501 (-4.7A)	1.18A	5v5zA-4zchA: undetectable	5v5zA-4zchA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_A_ECLA1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	PHE A 353 LEU A 56 ILE A 158 ALA A 256	None None 144 A 501 ( 4.2A) None	0.78A	6b5vA-4zchA: undetectable 6b5vC-4zchA: undetectable	6b5vA-4zchA: 10.80 6b5vC-4zchA: 10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_C_ECLC1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	PHE A 353 LEU A 56 ILE A 158 ALA A 256	None None 144 A 501 ( 4.2A) None	0.78A	6b5vC-4zchA: undetectable 6b5vD-4zchA: undetectable	6b5vC-4zchA: 10.80 6b5vD-4zchA: 10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_D_ECLD1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	4 / 7	ALA A 256 PHE A 353 LEU A 56 ILE A 158	None None None 144 A 501 ( 4.2A)	0.80A	6b5vB-4zchA: undetectable 6b5vD-4zchA: undetectable	6b5vB-4zchA: 10.80 6b5vD-4zchA: 10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGC_A_ACTA811_0 (GEPHYRIN)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	3 / 3	LEU A 267 LEU A 261 ARG A 222	None	0.70A	6fgcA-4zchA: undetectable	6fgcA-4zchA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA810_0 (GEPHYRIN)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	3 / 3	LEU A 117 LEU A 111 ARG A 76	None	0.63A	6fgdA-4zchA: undetectable	6fgdA-4zchA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA810_0 (GEPHYRIN)	4zch	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (Homo sapiens)	3 / 3	LEU A 267 LEU A 261 ARG A 222	None	0.64A	6fgdA-4zchA: undetectable	6fgdA-4zchA: 22.06

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1TMX_B_BEZB882_0","HYDROXYQUINOL 1,2-DIOXYGENASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"LEU A 431;TYR A 360;ILE A 429;HIS A 369;VAL A 325","None","1.37A","1tmxB-4zchA:undetectable","1tmxB-4zchA:21.74"],["1VE3_A_SAMA302_0","HYPOTHETICAL PROTEIN PH0226","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"ALA A 256;GLY A 205;SER A 105;ILE A 203;PHE A 353","None","1.15A","1ve3A-4zchA:undetectable","1ve3A-4zchA:20.56"],["1VE3_B_SAMB301_0","HYPOTHETICAL PROTEIN PH0226","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"ALA A 256;GLY A 205;SER A 105;ILE A 203;PHE A 353","None","1.14A","1ve3B-4zchA:undetectable","1ve3B-4zchA:20.56"],["2AOU_B_CQAB400_0","HISTAMINE N-METHYLTRANSFERASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"SER A 102;GLN A  60;TYR A 254;VAL A 108;PHE A 353","None","1.37A","2aouB-4zchA:0.0","2aouB-4zchA:21.67"],["2ZIA_B_CL9B401_1","DEOXYCYTIDINE KINASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"VAL A 174;TRP A 176;LEU A 269;PHE A 286;TYR A 254","None","1.28A","2ziaB-4zchA:undetectable","2ziaB-4zchA:21.78"],["2ZIA_B_CL9B401_1","DEOXYCYTIDINE KINASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"VAL A 325;TRP A 327;LEU A 420;PHE A 437;TYR A 405","None","1.29A","2ziaB-4zchA:undetectable","2ziaB-4zchA:21.78"],["2ZZN_A_SAMA401_0","UNCHARACTERIZED PROTEIN MJ0883","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"LEU A  56;PHE A 201;GLY A 288;ASP A 265;VAL A 195","None","1.28A","2zznA-4zchA:undetectable","2zznA-4zchA:21.30"],["4A79_A_P1BA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"LEU A 186;ILE A 203;ILE A 193;PHE A 286;TYR A 405","None","1.38A","4a79A-4zchA:undetectable","4a79A-4zchA:21.50"],["4A79_B_P1BB601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"LEU A 186;ILE A 203;ILE A 193;PHE A 286;TYR A 405","None","1.31A","4a79B-4zchA:undetectable","4a79B-4zchA:21.50"],["4A7A_A_RGZA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"LEU A 186;ILE A 203;ILE A 193;PHE A 286;TYR A 405","None","1.41A","4a7aA-4zchA:undetectable","4a7aA-4zchA:21.50"],["4EQ4_A_SALA601_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 420;THR A 436;ILE A 429;GLY A 368","None","0.97A","4eq4A-4zchA:undetectable","4eq4A-4zchA:21.64"],["4EQL_A_SALA602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 269;THR A 285;ILE A 278;GLY A 217","None","0.95A","4eqlA-4zchA:undetectable","4eqlA-4zchA:21.64"],["4EQL_A_SALA602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 420;THR A 436;ILE A 429;GLY A 368","None","0.94A","4eqlA-4zchA:undetectable","4eqlA-4zchA:21.64"],["4EQL_B_SALB602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 420;THR A 436;ILE A 429;GLY A 368","None","0.96A","4eqlB-4zchA:undetectable","4eqlB-4zchA:21.64"],["4L39_B_SALB601_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 269;THR A 285;ILE A 278;GLY A 217","None","0.87A","4l39B-4zchA:undetectable","4l39B-4zchA:21.64"],["4L39_B_SALB601_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"LEU A 420;THR A 436;ILE A 429;GLY A 368","None","0.88A","4l39B-4zchA:undetectable","4l39B-4zchA:21.64"],["4ZJL_D_ERYD1101_0","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"SER A 403;SER A  59;PHE A 286;LEU A  62;ASN A 251","None","1.45A","4zjlD-4zchA:undetectable","4zjlD-4zchA:18.34"],["5IGI_A_ZITA402_1","MACROLIDE 2'-PHOSPHOTRANSFERASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"ILE A 371;VAL A 358;ALA A 310;VAL A 325;PHE A 331","None","1.05A","5igiA-4zchA:undetectable","5igiA-4zchA:22.22"],["5JWA_H_ACTH612_0","NADH DEHYDROGENASE, PUTATIVE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",3,"ARG A  98;PRO A  93;ASN A 101","None","1.06A","5jwaA-4zchA:undetectable;5jwaH-4zchA:undetectable","5jwaA-4zchA:22.46;5jwaH-4zchA:22.46"],["5V5Z_A_1YNA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",5,"PHE A 136;PHE A  86;GLY A 408;LEU A  56;PHE A 109","None;None;None;None;144 A 501 (-4.7A)","1.18A","5v5zA-4zchA:undetectable","5v5zA-4zchA:21.55"],["6B5V_A_ECLA1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"PHE A 353;LEU A  56;ILE A 158;ALA A 256","None;None;144 A 501 ( 4.2A);None","0.78A","6b5vA-4zchA:undetectable;6b5vC-4zchA:undetectable","6b5vA-4zchA:10.80;6b5vC-4zchA:10.80"],["6B5V_C_ECLC1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"PHE A 353;LEU A  56;ILE A 158;ALA A 256","None;None;144 A 501 ( 4.2A);None","0.78A","6b5vC-4zchA:undetectable;6b5vD-4zchA:undetectable","6b5vC-4zchA:10.80;6b5vD-4zchA:10.80"],["6B5V_D_ECLD1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",4,"ALA A 256;PHE A 353;LEU A  56;ILE A 158","None;None;None;144 A 501 ( 4.2A)","0.80A","6b5vB-4zchA:undetectable;6b5vD-4zchA:undetectable","6b5vB-4zchA:10.80;6b5vD-4zchA:10.80"],["6FGC_A_ACTA811_0","GEPHYRIN","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",3,"LEU A 267;LEU A 261;ARG A 222","None","0.70A","6fgcA-4zchA:undetectable","6fgcA-4zchA:22.06"],["6FGD_A_ACTA810_0","GEPHYRIN","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",3,"LEU A 117;LEU A 111;ARG A  76","None","0.63A","6fgdA-4zchA:undetectable","6fgdA-4zchA:22.06"],["6FGD_A_ACTA810_0","GEPHYRIN","4zch","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B","Homo sapiens",3,"LEU A 267;LEU A 261;ARG A 222","None","0.64A","6fgdA-4zchA:undetectable","6fgdA-4zchA:22.06"]]